This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue from operations up 26%, profit after tax up 52%
ALKYLAMINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended September 30, 2026: revenue from operations rose 26.1% to Rs 490.95 crore from Rs 389.41 crore a year earlier, while profit after tax rose 51.8% to Rs 65.17 crore from Rs 42.94 crore. Operating profit before interest, tax, depreciation and amortisation had a 19.9% margin, up from 18.0%. Standalone half-year revenue was Rs 1,018.96 crore, profit after tax Rs 159.80 crore and operating cash flow Rs 48.25 crore.
Revenue, profit and margin growth support positive shareholder sentiment, though higher inventories and receivables remain watch points.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹491.0 Cr | ₹389.4 Cr | +26.1% |
| Operating profit | ₹79.32 Cr | ₹51.69 Cr | +53.5% |
| Profit after tax | ₹65.17 Cr | ₹42.94 Cr | +51.8% |
| EBITDA margin | 19.9% | 18.0% | +1.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.